Source: Annual Congress 2003 - Smoking habits with focus on health care personel
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Latinovic, R. Gajanin, Z. Eri, I. Klem, D. Janicic, V. Gajanin, B. Jefic (Banja Luka, Bosnia; Sremska Kamenica, Novi Sad, Yugoslavia). Immunohistochemical detection of p53 oncoprotein in human oral squamos cell carcinomas: Correlation with histological grade and tobacco habits. Eur Respir J 2003; 22: Suppl. 45, 3097

Member's Comments

No comment yet.

Related content which might interest you: Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004 Prognostic significance of p53 and Ki-67 expression in Patients with Resected Lung squamous cell carcinoma Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Differentiation between squamous cell carcinoma (SCC) and adenocarcinoma (AC): Expression of immunohistochemical (IHC) markers in a tissue microarray (TMA) of >1000 NSCLC Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease Year: 2011 Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53 Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006 Immunohistochemical expression of Bcl-2 and p53 in patients with lung cancer: Correlation with survival time Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 The value of AXL expression in squamous cell carcinoma of the lung: relationship with clinicopathological parameters. Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 COX-2 expression during early lung squamous cell carcinomas oncogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 Her-2/neu expression in advanced non small cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Immunohistochemical expression of Hsp27 and alphaB-crystallin in different histological subtypes of lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Expression of caveolin-1 and ttf-1 in lung adenocarcinomas with various histological subtypes Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Loss of heterozygosity off the P16, P53 and APC gene in oral cavity exfoliate cytologic material among lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 457s Year: 2005 Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential Source: Eur Respir J 2001; 18: Suppl. 33, 19s Year: 2001 HER-2/neu overexpression in patients with lung carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Karyometric analysis of squamous metaplasia, dysplasia and squamous cell carcinoma of the lung Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009